CTF1 and obstructive sleep apnea syndrome: It was shown that the concentration of CT-1 in the serum was higher in patients with OSA compared to the control group without OSA, and based on these findings, it has been hypothesized that CT-1 may be an early biomarker for OSA detection [22].